Cap 1 Messenger RNA Synthesis with Co‐transcriptional CleanCap ® Analog by In Vitro Transcription

Henderson, Jordana M., Ujita, Andrew, Hill, Elizabeth, Yousif‐Rosales, Sally, Smith, Cory, Ko, Nicholas, McReynolds, Taylor, Cabral, Charles R. +2 more·2021·Current Protocols
DOI 10.1002/cpz1.39

Cited by (231)

Items 201–231 of 231

  1. mRNA vaccines: The new frontier
    Zhipeng Yan, Ming Jin Yang, Elaine Tian, Ching‐Lung Lai · 2025 · Elsevier eBooks
  2. Large-Scale Production of Unmodified mRNA for Reprogramming Human Dendritic Cells and T Cells
    Stein Sæbøe‐Larssen, Mouldy Sioud · 2025 · Methods in molecular biology
  3. Generating mRNA Encoding Anti-HBV Designer Epigenome Modifiers
    Prashika Singh, Tafadzwa Mlambo, Kristie M. Bloom, Claudio Mussolino, Patrick B. Arbuthnot, Abdullah Ely · 2025 · Methods in molecular biology
  4. Engineering Linear Cap-independent mRNA Vaccines with Intrinsic Adjuvanticity for Potent Cancer Immunotherapy
    Hongwu Yu, Yu Yang, Peng Lin, Chengye Liu, Yifan Wen, Zhuting Fang, Zhixiang Hu, Shenglin Huang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Engineering bone tissue with mRNA: from molecular design and delivery to clinical applications
    Claudia Del Toro Runzer, Martijn van Griensven, Elizabeth Rosado Balmayor · 2025 · Materials Today
  6. Minimal Polymerase-Containing Precursor Required for Chikungunya Virus RNA Synthesis
    David Aponte-Diaz, Abha Jain, Jayden M. Harris, Jamie J. Arnold, Craig E. Cameron · 2025 · Viruses
  7. The research progress on the design and application of mRNA antibody technology
    Feixue Du, X.Z. Xiong, Hang Chi, Yongqiang Deng, Xiaodong Han · 2025 · Chinese Science Bulletin (Chinese Version)
  8. In vitro expression and seroreactivity of Toxoplasma gondii GRA1 protein encoded by unmodified and nucleoside-modified mRNA constructs
    Mehmet Nadir Şahinci, Mert Döşkaya, Muhammet Karakavuk, Seren Kaplan, Gizem Mutlu, Tuğçe Gizem Perçin, Sedef Erkunt Alak, Özlem Günay-Esiyok, Aytül Gül, Aysu Değirmenci Döşkaya et al. · 2025 · Gene
  9. A Combinatorial mRNA Therapy for Treating Rheumatoid Arthritis and Osteoarthritis by Inhibiting Inflammation and Promoting Cartilage Regeneration
    Guan Wang, Yixuan Guo, Kun Guo, Cheng Zhang, Ying Zhou, Jiayuan Xia, Jiaqing Liu, Jinyi Ren, Ahmed Osman Mohamed, Ke Tang et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Engineering of enzymatic modules for mRNA manufacturing: Advances in catalytic regulation and process integration
    Shiyi Che, Zhengjun Li, Zhiguo Su, Zhikao Li, Aibing Yu, Minsu Liu, Songping Zhang · 2026 · CHINESE JOURNAL OF CATALYSIS (CHINESE VERSION)
  11. Molecular medicine driven by nucleic acid modifications: state of the field, challenges, and opportunities
    Yan Huang, Ling Zhu, Xiaocheng Weng, Peng Chen, Xiang Zhou, Junlin Yang · 2026 · Scientia Sinica Chimica
  12. Protocol to annotate dendritic cell maturation types in vivo making use of lipid nanoparticle-based approaches
    Karo Van Lil, Janne Swinnen, Greta R. Webb, Sofie Rennen, Victor Bosteels, Sandra Maréchal, Clint De Nolf, Jessica Vetters, Jiří Březina, Evelien Van De Velde et al. · 2026 · STAR Protocols
  13. Deciphering the Mechanism: Overcoming Incompatibility for Continuous Cap-1 mRNA Synthesis via Multienzyme Cascades
    Shiyi Che, Zhengjun Li, Zhiguo Su, Aibing Yu, Minsu Liu, Songping Zhang · 2026 · ACS Sustainable Chemistry & Engineering
  14. Optimization of a liver Trm cell-inducing mRNA vaccine by reduction of type I interferon response
    Jordan James Minnell, Mitch Ganley, Ariane R. Lee, Taylah Phabmixay, Kathryn J. Farrand, Olivia K. Burn, John C. Mamum, Emma Lamb, Sarah L. Draper, Susanna T. S. Chan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Formation and evolution of China’s mRNA platform technology: from COVID-19 vaccines to next-generation therapeutics
    Jinzhong Lin · 2026 · Scientia Sinica Vitae
  16. Thio-modification effects on mRNA translation using a PureCap-based capping method
    Zheyu Meng, Yiwei Liu, Yuko Nakashima, Masahito Inagaki, Seigo Kimura, Yukari Kondo, Fumitaka Hashiya, Naoko Abe, Noriko Saito–Tarashima, Noriaki Minakawa et al. · 2026 · RSC Chemical Biology
  17. Streamlined In Vitro Transcription for Generating Self‐Amplifying RNA With Modified Nucleotides
    Harish Prakash, Karthik Kadhir Velu, Vasanth Thamodaran · 2026 · Current Protocols
  18. Rapid LC–MS Quantification of mRNA Vaccine Capping Efficiency via High-Specificity RNase H Cleavage and Metal Adduct Suppressed Chromatography
    Ren Yang, Xiaohong Wu, Xiaowei Zhang, Shengqing Fu, Kaiping Gu, Zhe Lv, X Q Li, Qunying Mao · 2026 · Vaccines
  19. DNA template heterogeneity and in vitro transcription reaction conditions impact the poly(A) tail length and heterogeneity of mRNA
    Gareth R. Owen, Caroline A. Evans, Adithya Nair, Sebastian J. Ross, Mollie A. Glenister, Zoltan Kis, Mark J. Dickman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Circular Photocaged mRNA for Light‐induced Late‐stage Activation of Translation
    Bayram Terzi, Greta Charlotte Dahm, Heintz Kg, Martin Sumser, Yasuaki Kimura, Hiroshi Abe, Andrea Rentmeister · 2026 · Angewandte Chemie International Edition
  21. Zirkuläre, Photogeschützte mRNA für Lichtinduzierte Aktivierung der Translation zu späten Zeitpunkten
    Bayram Terzi, Greta Charlotte Dahm, Heintz Kg, Martin Sumser, Yasuaki Kimura, Hiroshi Abe, Andrea Rentmeister · 2026 · Angewandte Chemie
  22. A Luciferase-Based Assay for Assessing Cap-Independent Translation in Wheat Germ Extract
    Max Cortot, Thorsten Stehlik, Aline Koch, Timo Schlemmer · 2026 · BIO-PROTOCOL
  23. Two Classes of Protein Therapeutics: Why Dose–Response Architecture Defines the Boundary of mRNA Medicines
    Sarfaraz K. Niazi · 2026 · Pharmaceutics
  24. Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics
    Konstantina Athanasopoulou, Glykeria N. Daneva, Vasiliki-Ioanna Michalopoulou, Maria-Lavrentia Stamelou, Panagiotis Tsiakanikas, Panagiotis G. Adamopoulos · 2026 · Current Issues in Molecular Biology
  25. Preclinical Development of ARV-2001, an Intradermally Administered mRNA–Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions
    Zhengxiang He, Huabin Zhu, Ju Hyeong Jeon, Jianzhu Chen, Gregory M. Glenn, Renhuan Xu · 2026 · Vaccines
  26. Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing
    Adithya Nair, Jixin Qu, Manoj Baliram Pohare, Thomas C. Minshull, Caroline A. Evans, Klaudia M. Slowik, Kate A. Loveday, Zoe V.R. Ashcroft, Mabrouka Maamra, Helen Elizabeth Colley et al. · 2026 · Molecular Therapy — Nucleic Acids
  27. Next-generation CAR therapies enabled by mRNA engineering and delivery
    Qinghao Zhao, Qinqin Wen, Peizhen Pu, Caili Xu, Qinchao Hu, Zhuoran Zhou, Xianxin Hua, Xuyao Zhang · 2026 · Acta Pharmaceutica Sinica B
  28. A review of mRNA vaccines and host-directed therapeutics for multidrug-resistant ESKAPE pathogens
    Emmanuel Okoro Enyi, Joy Chimuanya Nnanna · 2026 · Discover Bacteria.
  29. A Platform Approach to mRNA Purification by Tangential Flow Filtration: Application to a Pentavalent Norovirus Vaccine
    Emily A. Dewar, Andrew R. Swartz, Keira Tuberty, Adam Gouveia · 2026 · Vaccines
  30. Advances and Challenges in mRNA Cancer Vaccines: Individualized Design and Delivery
    Liyun Huang, Yuting Tang, Xiaobing Chen, Zhen Wu, Junlan Xiao, Qi Xiang, Huajian Tian · 2026 · Bioengineering
  31. Epitope-guided optimization improves the protective efficacy of NA-based mRNA vaccines against seasonal influenza A(H3N2) virus
    Hyunbeen Kim, Sangyi Lee, Seunghye Cho, Woojin Shin, Soyoung Lee, Atanas Vladimirov Demirev, Taeyoung Lee, You-Jin Kim, Dokeun Kim, Sae Am Song et al. · 2026 · The Journal of Microbiology